Clinical Trials Browser

Phase 2 × OTHER_GOV × Drug Therapy × Clear all

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Liver Metastases

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

Unresectable Non-small Cell Lung Cancer

NCT06670911 2025-02-24

ACCESS-I

Phase 2 Recruiting

Recurrence

NCT06765616 2025-01-09

Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT04681287 2023-09-25

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

Phase 2 Unknown

HER2 Positive Metastatic Breast Cancer

NCT02621333 2021-05-12

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Phase 2 Terminated

Adenocarcinoma of Lung

NCT04319471 2020-03-24

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT03985670 2019-12-12

Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT00452803 2010-07-12

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms